Lowell Hart to Survival Analysis
This is a "connection" page, showing publications Lowell Hart has written about Survival Analysis.
Connection Strength
0.016
-
Lilenbaum R, Socinski MA, Altorki NK, Hart LL, Keresztes RS, Hariharan S, Morrison ME, Fayyad R, Bonomi P. Randomized phase II trial of docetaxel/irinotecan and gemcitabine/irinotecan with or without celecoxib in the second-line treatment of non-small-cell lung cancer. J Clin Oncol. 2006 Oct 20; 24(30):4825-32.
Score: 0.016